▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2080 by analyst upside · 2026-08-13
ARAY
Accuray Incorporated
Healthcare · Market Cap $33M · P/E 0x
ANALYST PRICE TARGET
+25.0%
implied upside to consensus target
Current Price $0.28
Consensus Target $0.35
Bull Target $0.35
Bear Target $0.35
Analysts Covering 1
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
1
Sell
0
52-Week Low $0.22
52-Week High $2.1
YTD Return -67.1%
FUNDAMENTALS
Market Cap $33M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.37
PEG Ratio 29.49
Dividend Yield N/A
Revenue (TTM) $429M
Profit Margin -10.8%
52-WEEK RANGE
52-Week Low $0.22
52-Week High $2.1
Current Price $0.28
Bear Target $0.35
Bull Target $0.35
● Now $0.28 ● Target $0.35
TRADING DATA
Avg Volume 3.4M
YTD Return -67.1%
Analyst Count 1
Consensus Hold
Upside to Target +25.0%
Last Updated 2026-08-13

ANALYST SUMMARY

Accuray Incorporated (ARAY) is currently trading at $0.28 with a Wall Street consensus price target of $0.35, implying potential upside of 25.0% over the next 12 months. 1 analysts currently cover ARAY, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $0.35, while the most cautious has a target of $0.35.

ARAY operates in the Healthcare sector with a market capitalisation of $33M. The stock is down 67.1% year-to-date and is currently trading near the lower end of its 52-week range of $0.22 – $2.1.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

TCMD +56.1%
Tactile Systems Technology, Inc.
$555M · P/E 22.9x · Buy
JYNT +15.2%
The Joint Corp.
$123M · P/E 62.0x · Hold
SLP -5.8%
Simulations Plus, Inc.
$371M · P/E 45.8x · Hold
OMCL +55.8%
Omnicell, Inc.
$2B · P/E 44.2x · Buy
BLFS -10.5%
BioLife Solutions, Inc.
$2B · P/E 35.0x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for ARAY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Jefferies ↓ Downgrade
Buy → Hold 2026-05-12 50% win rate (6 calls)
BTIG ↓ Downgrade
Buy → Neutral 2026-05-07 38% win rate (8 calls)
BTIG - Reiterated
Buy → Buy 2026-02-05 38% win rate (8 calls)
BTIG - Reiterated
Buy → Buy 2025-11-06 38% win rate (8 calls)
BTIG - Reiterated
Buy → Buy 2025-08-14 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
15
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →